# Real world outcomes with <scp>Bortezomib Thalidomide dexamethasone</scp> and <scp>Cyclophosphamide Bortezomib dexamethasone</scp> induction treatment for transplant eligible multiple myeloma patients in a Latin American country. A Retrospective Cohort Study from Grupo Argentino de Mieloma Múltiple

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/real-world-outcomes-with-scp-bortezomib-thalidomide-dexamethasone-scp-and-scp/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Natalia Schütz,Paola Ochoa,Patricio Duarte,Guillermina Remaggi,Sebastián Yantorno,Ariel Corzo,Soledad Zabaljauregui,Claudia Shanley,Sergio Lopresti,Sérgio Orlando,Verónica Verri,Luis Quiroga,Carlos Alexandre Borges Garcia,Vanesa Fernández,Dorotea Fantl |
| Citations | 10 |
| DOI | 10.1002/hon.2729 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3012415529 |
| PMID | 32196120 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Patricio Duarte](https://scholariq.org/researchers/patricio-duarte/)

## Paper primary topic

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)

## Paper topics

- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Myeloproliferative Neoplasms: Diagnosis and Treatment](https://scholariq.org/topics/myeloproliferative-neoplasms-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.